Volasertib in Combination With Low-dose Cytarabine in Patients Aged 65 Years and Above With Previously Untreated Acute Myeloid Leukaemia, Who Are Ineligible for Intensive Remission Induction Therapy (POLO-AML-2)
Clinical trial NCT01721876 · COMPLETED
Trial details
- NCT number
- NCT01721876
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-01-29
- Primary completion
- 2014-08-12
- Enrollment
- 666
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.